Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

Jaap A. Van Doesum, Jon Salmanton-García, Francesco Marchesi, Roberta Di Blasi, Iker Falces-Romero, Alba Cabirta, Francesca Farina, Caroline Besson, Barbora Weinbergerová, Jens Van Praet, Martin Schönlein, Alberto López-García, Sylvain Lamure, Anna Guidetti, Cristina De Ramón-Sánchez, Josip Batinić, Eleni Gavriilaki, Athanasios Tragiannidis, Maria Chiara Tisi, Gaëtan PlantefeveVerena Petzer, Irati Ormazabal-Vélez, Joyce Marques De Almeida, Monia Marchetti, Johan Maertens, Marina Machado, Austin Kulasekararaj, José-Ángel Hernández-Rivas, Maria Gomes Da Silva, Noemí Fernández, Ildefonso Espigado, Ľuboš Drgoňa, Giulia Dragonetti, Elisabetta Metafuni, Maria Calbacho, Ola Blennow, Dominik Wolf, Bjorn Van Anrooij, Raquel Nunes Rodrigues, Anna Nordlander, Juan-Alberto Martín-González, Raphaël Liévin, Moraima Jiménez, Stefanie K. Gräfe, Ramón García-Sanz, Raúl Córdoba, Laman Rahimli, Tom Van Meerten, Oliver A. Cornely, Livio Pagano

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey'. Insieme formano una fingerprint unica.

Immunology and Microbiology

Medicine and Dentistry